Her2 Positive Gastric Cancer Market | Size, Share, Growth

Her2 Positive Gastric Cancer Market Research Report - Size, Share, Growth, and Trend Analysis | Forecast (2025 - 2030)

Published: 2025 - March

Report Code: VMR-18249

Region: Global

Request Sample

Customization

Ask an Expert

Enquire Enquire Before Buying

Her2 Positive Gastric Cancer Market (2025-2030)

The HER2 Positive Gastric Cancer Market encompasses the diagnosis, treatment, and management of gastric cancer characterized by the overexpression of the HER2 (human epidermal growth factor receptor 2) protein. This subset of gastric cancer presents unique biological and clinical features, necessitating targeted therapeutic approaches to improve survival outcomes and quality of life. The market includes a diverse range of innovative biologics, antibody-drug conjugates, and combination therapies designed to address the unmet needs of patients.

Disruptive Impact and Opportunities:

The market is undergoing disruptive transformation, driven by emerging technologies and treatments. Groundbreaking therapies such as HER2-targeted ADCs and bispecific antibodies redefine treatment paradigms. Development of subcutaneous formulations and oral options simplifies administration and enhances patient compliance. Advanced drug designs focus on reducing systemic toxicity while maintaining efficacy. Significant growth potential driven by expanding patient populations and pipeline innovations.

Emerging Drugs:

Cinrebafusp alfa
BI-1607

Marketed Drugs:

Herceptin
Trastuzumab deruxtecan

Key Companies:

Pieris Pharmaceuticals
BioInvent International
Bellicum Pharmaceuticals
Mersana Therapeutics
Acepodia Biotech, Inc.
Klus Pharma Inc.
Carisma Therapeutics Inc.
Byondis
Celularity Incorporated

Market Segmentation:

By Type

Therapeutic Approach
- Monoclonal Antibodies
- Antibody-Drug Conjugates (ADCs)
- Small Molecule Inhibitors
- Immunotherapy Combinations
- Chemotherapy Combinations
Line of Therapy
- First-Line Treatment
- Second-Line Treatment
- Third-Line and Beyond
Mechanism of Action
- HER2 Inhibition
- Dual HER2/EGFR Inhibition
- HER2-targeted ADCs

By Administration Type

Route of Administration
- Intravenous (IV)
- Subcutaneous (SC)
- Oral
Dosage Form
- Injectable
- Tablets/Capsules
Frequency of Administration
- Single-Dose Regimens
- Multiple-Dose Regimens

What’s in It for You?

Identify opportunities in emerging therapies and novel mechanisms of action.
Benchmark competitor strategies and pipeline progress.
Assess market size, trends, and growth drivers for informed decision-making.
Guide investment decisions with data-backed forecasts and analysis.
Discover partnership and licensing opportunities in a rapidly evolving landscape.

Her2 Positive Gastric Cancer Market - Executive Summary
1. Introduction
2. Objectives
3. Key Findings
  1. Market Size 2025 & 2030: By Key Country (10MM)
  2. Global Market Size 2025 & 2030: By Key Segment
  3. Key Investments & Startup Analysis
4. Research Methodology
Understanding the Disease
1. Disease Overview
2. Classification
3. Signs and Symptoms
4. Risk Factors
5. Causes
6. Disease Biology & Digital Innovations
7. Stages & Staging System
8. Diagnostic Algorithm
9. Current Treatment Practices & Algorithm
10. Current Standard of Care and Treatment Gaps
11. Patient Demographics and Treatment Pathways
Guidelines
Unmet Needs
Epidemiology and Patient Population
1. Epidemiology Key Findings
2. Assumptions and Rationale: 10MM
3. Epidemiology Scenario: 10MM
4. U.S. Epidemiology Scenario
5. EU-5 Epidemiology
  1. U.K. Epidemiology Scenario
  2. Germany Epidemiology Scenario
  3. France Epidemiology Scenario
  4. Italy Epidemiology Scenario
  5. Spain Epidemiology Scenario
6. Japan Epidemiology Scenario
7. China Epidemiology Scenario
8. Australia Epidemiology Scenario
9. India Epidemiology Scenario
Real-world Data & Real-world Evidence
Drug Development Landscape
1. Existing Key Drug Candidate Profiles/ Marketed Therapies
2. Competitive Analysis and Differentiation
3. Overview of Similar/Competing Drugs in Clinical Trials
4. Future Trends and Emerging Drugs
Regulatory Strategy and Potential Challenges
1. Regulatory Pathways in Key Markets
2. Anticipated Regulatory Hurdles and Mitigation Strategies
3. Case Studies in Oncology Drug Regulation
4. Impact of Potential Changes to Regulatory Framework
Commercial Landscape
1. Market Size & Growth Rates
2. Key Approvals & Anticipated Loss of Exclusivity
3. PESTLE & Porter’s Five Forces Analysis
4. Market Shares, Positioning/Ranking
5. Market Drivers
6. Identification of Threats
7. Digital Evolution in Commercialization
Market Segmentation
Pricing, Reimbursement, and Access
1. Competitive Pricing Analysis
2. Reimbursement Landscape and Challenges
3. Strategies for Market Access and Equity
4. Patient Spending/Expenditure Analysis
Future Trends, Disruptions, and Opportunities
1. Analysis of Emerging Trends
2. Technological Impact
3. Impact of Potential Market Disruptors
4. Opportunities for Future Development and Expansion
5. Considerations for Investment Opportunities
Global Market Dynamics
1. Regional Regulatory Disparities
2. Cross-Border Partnership Strategies
3. Global Supply Chain Dynamics
4. Case Studies: Success and Failure in Global Markets
5. Strategies for Global Expansion and Localization
Company Profiles

Download Sample

Full Name *

Job Title *

Company *

Email *

Phone *

Country *

Message

↻

The field with (*) is required.

Choose License Type

Excel Data Pack

2500

Single User

4250

Multi User

5250

Corporate User

6900